V019-1329 Screening compound: 1-(2-methylpropyl)-4-[6-(pentan-2-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-1,4-diazepane

V019-1329 Screening compound: 1-(2-methylpropyl)-4-[6-(pentan-2-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-1,4-diazepane
V019-1329 Screening compound: 1-(2-methylpropyl)-4-[6-(pentan-2-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-1,4-diazepane alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-1329
1-(2-methylpropyl)-4-[6-(pentan-2-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-1,4-diazepane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-1329

Molecular Formula

C25H36N6 (C25 H36 N6)

Compound Name

1-(2-methylpropyl)-4-[6-(pentan-2-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-1,4-diazepane

IUPAC name

1-(2-methylpropyl)-4-[6-(pentan-2-yl)-1-phenyl-1H-pyrazolo[34-d]pyrimidin-4-yl]-14-diazepane

SMILES

CCCC(C)c1nc(n(-c2ccccc2)nc2)c2c(N2CCN(CC(C)C)CCC2)n1

InChI

InChI=1S/C25H36N6/c1-5-10-20(4)23-27-24(30-14-9-13-29(15-16-30)18-19(2)3)22-17-26-31(25(22)28-23)21-11-7-6-8-12-21/h6-8,11-12,17,19-20H,5,9-10,13-16,18H2,1-4H3/t20-/m0/s1

InChI Key

MQUHPGUBAAUNJM-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD19859379

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

420.6

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.148

Distribution Coefficient, logD

5.024

Water Solubility, LogSw

-5.71

Polar Surface Area

40.765

Acid Dissociation Constant (pKa)

21.46

Base Dissociation Constant (pKb)

8.49

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

56.00

V019-1329 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V019-1329 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-1329?
Check Price and Availability of V019-1329, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-1329 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-1329
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-1329
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-1329 available by request